Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 13.03% is 72% above its 5-year average of 7.60%, near the high end of its 5-year range (-0.54%–13.03%).
As of the fiscal period ended Wednesday, December 31, 2025. 11.70% above its 12-month average of 11.66%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
13.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
11.66%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
9.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
7.60%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
7.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
8.62%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
12.76%
CURRENT VS TTM AVG
+11.70%
CURRENT VS 3Y AVG
+38.54%
CURRENT VS 5Y AVG
+71.56%
CURRENT VS 10Y AVG
+72.31%
CURRENT VS 15Y AVG
+51.16%
CURRENT VS 20Y AVG
+2.14%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+52.75%
vs the sector median at left
AstraZeneca PLC
Market Cap
$134.31B
Return on Invested Capital (ROIC)
13.03%
TTM Avg
11.66%
3Y Avg
9.40%
5Y Avg
7.60%
Market Cap
$135.04B
Return on Invested Capital (ROIC)
8.53%
TTM Avg
10.14%
3Y Avg
10.34%
5Y Avg
10.08%
Market Cap
$135.15B
Return on Invested Capital (ROIC)
4.72%
TTM Avg
4.17%
3Y Avg
4.46%
5Y Avg
4.93%
Market Cap
$138.17B
Return on Invested Capital (ROIC)
5.72%
TTM Avg
5.90%
3Y Avg
6.54%
5Y Avg
6.70%
Market Cap
$128.85B
Return on Invested Capital (ROIC)
13.90%
TTM Avg
13.75%
3Y Avg
11.92%
5Y Avg
10.17%
Market Cap
$143.34B
Return on Invested Capital (ROIC)
8.84%
TTM Avg
9.06%
3Y Avg
10.60%
5Y Avg
10.43%
Market Cap
$124.74B
Return on Invested Capital (ROIC)
13.71%
TTM Avg
12.85%
3Y Avg
12.25%
5Y Avg
11.92%
Market Cap
$122.67B
Return on Invested Capital (ROIC)
18.12%
TTM Avg
10.38%
3Y Avg
14.75%
5Y Avg
17.51%
Market Cap
$112.06B
Return on Invested Capital (ROIC)
6.13%
TTM Avg
6.11%
3Y Avg
5.46%
5Y Avg
5.53%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AstraZeneca PLC (AZN) | $134.31B | 13.03% | 11.66% | 9.40% | 7.60% |
| Stryker Corporation (SYK)vs › | $135.04B | 8.53% | 10.14% | 10.34% | 10.08% |
| CVS Health Corp. (CVS)vs › | $135.15B | 4.72% | 4.17% | 4.46% | 4.93% |
| Danaher Corporation (DHR)vs › | $138.17B | 5.72% | 5.90% | 6.54% | 6.70% |
| Bristol-Myers Squibb Company (BMY)vs › | $128.85B | 13.90% | 13.75% | 11.92% | 10.17% |
| Pfizer Inc. (PFE)vs › | $143.34B | 8.84% | 9.06% | 10.60% | 10.43% |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.74B | 13.71% | 12.85% | 12.25% | 11.92% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $122.67B | 18.12% | 10.38% | 14.75% | 17.51% |
| Medtronic plc (MDT)vs › | $112.06B | 6.13% | 6.11% | 5.46% | 5.53% |
| GSK plc (GSK)vs › | $106.59B | 16.61% | 12.56% | 12.53% | 10.40% |
ROIC
13.0%
ROE
21.9%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 13.03% |
| 2024-12-31 | 10.30% |
| 2023-12-31 | 9.32% |
| 2022-12-31 | 4.97% |
| 2021-12-31 | -0.54% |
| 2020-12-31 | 8.49% |
| 2019-12-31 | 5.12% |
| 2018-12-31 | 7.34% |
| 2017-12-31 | 7.47% |
| 2016-12-31 | 9.48% |
| 2015-12-31 | 8.20% |
| 2014-12-31 | 4.84% |
| 2013-12-31 | 7.02% |
| 2012-12-31 | 16.48% |
| 2011-12-31 | 26.53% |
| 2010-12-31 | 21.44% |
| 2009-12-31 | 20.55% |
| 2008-12-31 | 18.70% |
| 2007-12-31 | 15.40% |
| 2006-12-31 | 28.28% |
| 2005-12-31 | 25.47% |
| 2004-12-31 | 18.00% |
| 2003-12-31 | 18.66% |
| 2002-12-31 | 21.08% |
| 2001-12-31 | 17.18% |
| 2000-12-31 | 20.65% |
| 1999-12-31 | 18.37% |
| 1998-12-31 | 28.60% |
| 1997-12-31 | 22.12% |
| 1996-12-31 | 20.84% |
